Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

被引:31
作者
Zakharia, Kais [1 ]
Tabibian, Anilga [2 ]
Lindor, Keith D. [3 ,4 ]
Tabibian, James H. [5 ]
机构
[1] Beaumont Hlth Dearborn, Internal Med Residency Program, Dearborn, MI USA
[2] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA
[3] Arizona State Univ, Phoenix, AZ USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ USA
[5] Olive View UCLA Med Ctr, Dept Med, Div Gastroenterol, 14445 Olive View Dr, Sylmar, CA 91342 USA
关键词
biliary tract diseases; pharmacotherapy; primary biliary cholangitis; primary sclerosing cholangitis; pruritus; PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; INFLAMMATORY-BOWEL-DISEASE; MINIMAL HEPATIC-ENCEPHALOPATHY; DOSE URSODEOXYCHOLIC ACID; BONE-MINERAL DENSITY; ULCERATIVE-COLITIS; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; ALKALINE-PHOSPHATASE;
D O I
10.1111/liv.13591
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cholestatic liver diseases (CLDs) encompass a variety of disorders of bile formation and/or flow which generally result in progressive hepatobiliary injury and ultimately end-stage liver disease. Many patients with CLD are diagnosed between the ages of 20-50years, a particularly productive period of life professionally, biologically and in other respects; it is not surprising, thus, that CLD is often associated with impaired health-related quality of life (HRQOL) and uncertainty regarding implications for and outcomes of pregnancy. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are the most prominent CLDs, both having considerable morbidity and mortality and representing major indications for liver transplantation. These disorders, as a consequence of their complications (eg ascites, hepatic osteodystrophy), associated conditions (eg inflammatory bowel disease) and symptoms (eg pruritus and fatigue), can significantly impair an array of domains of HRQOL. Here we review these impactful clinical aspects of PSC and PBC as well as the topics of fertility and pregnancy.
引用
收藏
页码:399 / 411
页数:13
相关论文
共 146 条
[1]   Fatigue in primary biliary cirrhosis [J].
Abbas, Ghulam ;
Jorgensen, Roberta A. ;
Lindor, Keith D. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (06) :313-319
[2]   Pregnancy with Portal Hypertension [J].
Aggarwal, Neelam ;
Negi, Neha ;
Aggarwal, Aakash ;
Bodh, Vijay ;
Dhiman, Radha K. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2014, 4 (02) :163-171
[3]   Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis [J].
Al Mamari, Said ;
Djordjevic, Jelena ;
Halliday, John S. ;
Chapman, Roger W. .
JOURNAL OF HEPATOLOGY, 2013, 58 (02) :329-334
[4]   The Specificity of Fatigue in Primary Biliary Cirrhosis: Evaluation of a Large Clinic Practice [J].
Al-Harthy, Nadya ;
Kumagi, Teru ;
Coltescu, Catalina ;
Hirschfield, Gideon M. .
HEPATOLOGY, 2010, 52 (02) :562-570
[5]   Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: Case reports [J].
Alallam, Alallam ;
Barth, David ;
Heathcote, E. Jenny .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 2008, 22 (05) :505-507
[6]   Emerging drugs for the treatment of Primary Biliary Cholangitis [J].
Ali, Ahmad H. ;
Tabibian, James H. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (01) :39-56
[7]   Inflammatory bowel disease in pregnancy [J].
Alstead, EM ;
Nelson-Piercy, C .
GUT, 2003, 52 (02) :159-161
[8]   Does Primary Sclerosing Cholangitis Impact Quality of Life in Patients with Inflammatory Bowel Disease? [J].
Ananthakrishnan, Ashwin N. ;
Beaulieu, Dawn B. ;
Ulitsky, Alex ;
Zadvornova, Yelena ;
Skaros, Sue ;
Johnson, Kathryn ;
Naik, Amar ;
Perera, Lilani ;
Issa, Mazen ;
Binion, David G. ;
Saeian, Kia .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (03) :494-500
[9]   Primary sclerosing cholangitis [J].
Angulo, P ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (01) :325-332
[10]   Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression [J].
Angulo, P ;
Therneau, TM ;
Jorgensen, RA ;
DeSotel, CK ;
Egan, KS ;
Dickson, ER ;
Hay, JE ;
Lindor, KD .
JOURNAL OF HEPATOLOGY, 1998, 29 (05) :729-735